These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36708565)

  • 1. The Effect of Salmonella AvrA Infection on Colon Cancer: An in-silico Study.
    Wibowo BP; Kalim H; Khotimah H; Sujuti H; Wibowo RA
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):163-170. PubMed ID: 36708565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmonella Protein AvrA Activates the STAT3 Signaling Pathway in Colon Cancer.
    Lu R; Wu S; Zhang YG; Xia Y; Zhou Z; Kato I; Dong H; Bissonnette M; Sun J
    Neoplasia; 2016 May; 18(5):307-316. PubMed ID: 27237322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
    Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
    [No Abstract]   [Full Text] [Related]  

  • 4. Eukaryotic signaling pathways targeted by Salmonella effector protein AvrA in intestinal infection in vivo.
    Liu X; Lu R; Xia Y; Wu S; Sun J
    BMC Microbiol; 2010 Dec; 10():326. PubMed ID: 21182782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway.
    Lu R; Wu S; Zhang YG; Xia Y; Liu X; Zheng Y; Chen H; Schaefer KL; Zhou Z; Bissonnette M; Li L; Sun J
    Oncogenesis; 2014 Jun; 3(6):e105. PubMed ID: 24911876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of mismatch repair deficiency, CDX2, beta-catenin and E-cadherin expression in colon cancer: molecular characteristics and impact on prognosis and survival - an immunohistochemical study.
    Melincovici CS; Boşca AB; Şuşman S; Cutaş A; Mărginean M; Ilea A; Moldovan IM; Jianu EM; Neag MA; Bulboacă AE; Mihu CM
    Rom J Morphol Embryol; 2020; 61(3):715-727. PubMed ID: 33817713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the relationship of DNA mismatch repair with clinicopathologic features and prognosis of colon cancer].
    Qin Q; Ying J; Lyu N; Guo L; Zhi W; Zhou A; Wang J
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):591-6. PubMed ID: 26714599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2.
    Ten Broeke SW; van Bavel TC; Jansen AML; Gómez-García E; Hes FJ; van Hest LP; Letteboer TGW; Olderode-Berends MJW; Ruano D; Spruijt L; Suerink M; Tops CM; van Eijk R; Morreau H; van Wezel T; Nielsen M
    Gastroenterology; 2018 Sep; 155(3):844-851. PubMed ID: 29758216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
    Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H
    J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
    Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
    World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Regulatory Roles of Wnt1 in Infection-Associated Colorectal Cancer.
    Wang J; Lu R; Fu X; Dan Z; Zhang YG; Chang X; Liu Q; Xia Y; Liu X; Sun J
    Neoplasia; 2018 May; 20(5):499-509. PubMed ID: 29626750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutational profile of Chinese patients under 70 years old with colorectal cancer.
    Jiang TJ; Wang F; Wang YN; Hu JJ; Ding PR; Lin JZ; Pan ZZ; Chen G; Shao JY; Xu RH; Zhao Q; Wang F
    Cancer Commun (Lond); 2020 Nov; 40(11):620-632. PubMed ID: 32914570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
    Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J
    Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.
    Tamura K; Kaneda M; Futagawa M; Takeshita M; Kim S; Nakama M; Kawashita N; Tatsumi-Miyajima J
    Int J Clin Oncol; 2019 Sep; 24(9):999-1011. PubMed ID: 31273487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of Mismatch Repair Protein Deficiency in a Puerto Rican Population with Colonic Adenoma and Adenocarcinoma.
    Reverón D; López C; Gutiérrez S; Sayegh ZE; Antonia T; Dutil J; Malafa M; Coppola D
    Cancer Genomics Proteomics; 2018; 15(4):265-271. PubMed ID: 29976631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Tumoral MLH1-Expression in MLH1-/PMS2-Deficient Colon Cancer Is Indicative of Sporadic Colon Cancer and Not HNPCC.
    Tarancón-Diez M; Büttner R; Friedrichs N
    Pathol Oncol Res; 2020 Jul; 26(3):1435-1439. PubMed ID: 30613919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases.
    Rumilla K; Schowalter KV; Lindor NM; Thomas BC; Mensink KA; Gallinger S; Holter S; Newcomb PA; Potter JD; Jenkins MA; Hopper JL; Long TI; Weisenberger DJ; Haile RW; Casey G; Laird PW; Le Marchand L; Thibodeau SN
    J Mol Diagn; 2011 Jan; 13(1):93-9. PubMed ID: 21227399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of
    Lu R; Bosland M; Xia Y; Zhang YG; Kato I; Sun J
    Oncotarget; 2017 Aug; 8(33):55104-55115. PubMed ID: 28903406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.
    Kempers MJ; Kuiper RP; Ockeloen CW; Chappuis PO; Hutter P; Rahner N; Schackert HK; Steinke V; Holinski-Feder E; Morak M; Kloor M; Büttner R; Verwiel ET; van Krieken JH; Nagtegaal ID; Goossens M; van der Post RS; Niessen RC; Sijmons RH; Kluijt I; Hogervorst FB; Leter EM; Gille JJ; Aalfs CM; Redeker EJ; Hes FJ; Tops CM; van Nesselrooij BP; van Gijn ME; Gómez García EB; Eccles DM; Bunyan DJ; Syngal S; Stoffel EM; Culver JO; Palomares MR; Graham T; Velsher L; Papp J; Oláh E; Chan TL; Leung SY; van Kessel AG; Kiemeney LA; Hoogerbrugge N; Ligtenberg MJ
    Lancet Oncol; 2011 Jan; 12(1):49-55. PubMed ID: 21145788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.